Trial
NCT02819921
Desvenlafaxine for Treatment of Hot Flashes in Women With Breast Cancer Taking Tamoxifen
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Seoul National University Hospital
Collaborators
Seoul National University Bundang Hospital; Korea Cancer Center Hospital; Pfizer
Condition
Hot Flashes
Intervention
Desvenlafaxine succinate 100mg
Why stopped
Difficulty in Recruiting Research Participants
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-09-20